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Abstract
Background: There is individual variability to cardiorespiratory fitness (CRF) training, but the underlying cause is not
well understood. Traditionally, a standardized approach to exercise prescription has utilized relative percentages of
maximal heart rate, heart rate reserve (HRR), maximal oxygen uptake (VO2max), or VO2 reserve to establish exercise
intensity. However, this model fails to take into consideration individual metabolic responses to exercise and may
attribute to the variability in training responses. It has been proposed that an individualized approach would take
into consideration metabolic responses to exercises to increase responsiveness to training.
Methods: In this randomized control trial, participants will undergo a 12-week exercise intervention using
individualized (ventilatory thresholds) and standardized (HRR) methods to prescribe CRF training intensity. Following
the intervention, participants will be categorized as responders or non-responders based on changes in maximal
aerobic abilities. Participants who are non-responders will complete a second 12-week intervention in a crossover
design to determine whether they can become responders with a differing exercise prescription. There are four
main research outcomes: (1) determine the cohort-specific technical error to use in the categorization of response
rate; (2) determine if an individualized intensity prescription is superior to a standard approach in regards to
VO2max and cardiometabolic risk factors; (3) investigate the time course changes throughout 12 weeks of CRF
training between the two intervention groups; and (4) determine if non-responders can become responders if the
exercise prescription is modified.
Discussion: The findings from this research will provide evidence on the effectiveness of individualized exercise
prescription related to training responsiveness of VO2max and cardiometabolic risk factors compared to a
standardized approach and further our understanding of individual exercise responses. If the individualized
approach proposed is deemed effective, it may change the way exercise specialists prescribe exercise intensity to
enhance training responsiveness.
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Keywords: Responder, Non-responder, Exercise prescription, Ventilatory threshold, Cardiovascular disease, Primary
prevention
* Correspondence: rweatherwax@western.edu
1Auckland University of Technology, Human Potential Centre, Auckland, New
Zealand
3Department of Recreation, Exercise, and Sport Science, Western State
Colorado University, Gunnison, CO, USA
Full list of author information is available at the end of the article
© The Author(s). 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Weatherwax et al. Trials  (2016) 17:601 
DOI 10.1186/s13063-016-1735-0
Background
Heterogeneity in the response to exercise training first
received attention in the 1980s [1] with a series of stan-
dardized studies investigating trainability of sedentary
adults. Among these studies was an investigation into
responses of maximal aerobic power in which it was
reported that interindividual differences ranged from 5%
to 88% [2]. Even though these original findings were
reported over 30 years ago, substantial individual
variability in response to prescribed exercise regimes
remains a poorly understood phenomena. Nonetheless,
it has been purported that a more individualized ap-
proach to the exercise prescription may enhance training
efficacy and limit training unresponsiveness. For in-
stance, it has been acknowledged as far back as the late
1970s that utilizing a relative percent method (i.e., %
heart rate reserve [HRR]) to establish exercise intensity
fails to account for individual metabolic responses to
exercise [3]. Nevertheless, the relative percent concept
remains the gold standard recommendation for exercise
intensity [4]. It is both plausible and practical to think
that an intensity set based on an individual’s threshold
measurement (i.e. ventilatory threshold) will not only
encourage more positive physiological adaptations, but
may account for some of the variability in training re-
sponsiveness by taking into consideration individual
metabolic differences. Based on an extensive search of
the literature, to our knowledge, there is only one inves-
tigation that set out to determine the incidence of
response based on exercise prescription using standard
methods (%HRR) compared to individualized methods
(threshold based) in which they found 100% of the indi-
vidualized group responded in a positive manner [5].
However, this investigation had several limitations in-
cluding a modest intervention duration, only reported
maximal oxygen uptake (VO2max) changes, and sourced
measurements for biological variability to use as criteria
for response rate rather than testing for biological vari-
ability within the laboratory where data were collected.
A notable factor that confounds current understanding
of training response variability is the absence of a set
definition in the literature of how to interpret a response
(i.e. what classifies someone as a responder or non-
responder). Indeed, criteria to determine incidence of
response for changes in VO2max have included classify-
ing a fixed proportion of the lowest training response
[6], absolute changes in pre- to post-intervention values
[7, 8], and a change of more than one standard deviation
[9]. More recently, it has been proposed that technical
error (TE), the combination of day-to-day biological
variability and measurement error, should be applied to
categorize response rate [10]. If these values are consid-
ered for each research cohort to report incidence of re-
sponse, there would be greater consistency of reporting
results within the literature to provide further insight on
individual variability. Moreover, interpretation of the in-
dividual variability in training responsiveness is limited
due in part to the standard practice of past studies only
reporting group means and standard deviations. With
reporting of only the mean and standard deviation,
results of the intervention may not be applicable to all
since there is a lack of understanding related to the indi-
vidual variability of the investigation.
This trial will be the first investigation to address the in-
cidence of response of VO2max and cardiometabolic risk
factors following individualized and standardized cardiore-
spiratory fitness (CRF) training using a specific cohort-
calculated TE as the criteria for response. Similarly, this
will be the first study to evaluate the efficacy of modifying
the CRF training intensity prescription for non-responsive
participants (based on changes of VO2max) to investigate
subsequent training responsiveness.
Research aims
The objective of this research is to determine the inci-
dence of response to VO2max after implementation of a
standardized (%HRR) and individualized (based on first
ventilatory threshold [VT1] and second ventilatory
threshold [VT2]) approach to exercise prescription in a
community wellness program for 12 weeks. The primary
measurement outcome will be VO2max with secondary
outcomes of total cholesterol (TC), high-density lipopro-
tein (HDL), low-density lipoprotein (LDL), triglycerides,
blood glucose, and resting heart rate (HR) and blood
pressure (BP). Thus, the main research aim is to deter-
mine whether an individualized exercise prescription
decreases the incidence of non-response to CRF and
cardiometabolic measurements compared to the stan-
dardized approach. Similarly, another primary research
aim is to determine if changing the prescription of CRF
intensity for a subsequent 12-week intervention elicits
more responsiveness in previously categorized non-
responders (based on VO2max responses). A key sec-
ondary aim of this research is to establish whether there
are differences in the time course changes of VO2max
and cardiometabolic risk factors between the experimen-
tal groups every fourth week during the 12-week
intervention.
Methods/Design
The Standard Protocol Items: Recommendations for Inter-
ventional Trials (SPIRIT) guidelines [11] have been taken
into consideration for the planning of this trial (Additional
file 1). The overall study (Fig. 1) is a randomized control
trial with participants completing a CRF training study
3 days a week for a duration of 12 weeks using a standard-
ized (%HRR) and an individualized (based on VT1 and
VT2) approach (see Additional file 2: overall SPIRIT study
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schedule or Tables 1, 2 and 3 for SPIRIT schedule design).
If participants do not have a favorable outcome after
12 weeks (i.e. non-responders), they will complete a
second 12-week intervention with a crossover design
of the other exercise prescription. The protocol has
been approved by the Auckland University of Tech-
nology Ethics Committee (16/264) and the Human
Research Committee of the Institutional Review Board
at Western State Colorado University (HRC2016-01-
90R6) with data collection occurring only at Western
State Colorado University.
Sample – experimental groups
For the experimental groups, participants will be re-
cruited from a community-based wellness program
serving the local area. The wellness program partici-
pants are either referred by local medical profes-
sionals or seek entrance into the program from peer
referrals. In order for participants to be included in
the study, they must meet the following inclusion
criteria:
 30 to 75 years of age
 Considered low to moderate risk for cardiovascular
disease [4]
 Currently sedentary (participating in less than
30 minutes of moderate intensity physical activity on
at least 3 days a week)
 Resided at an altitude near 2300 m for at least the
last 6 months
Participants will be excluded from the study if they
have any signs, symptoms, or diagnosed cardiovascular,
pulmonary, or metabolic disease. During the trial, partic-
ipants will be asked to maintain their normal lifestyle to
ensure any adaptations were due to the intervention.
Sample – control group
Due to moral and ethical issues related to excluding
participants from an exercise intervention to improve
health, a control group will be recruited as a separate
cohort. The control group participants must meet the
same inclusion criteria and will not be allowed in the
study if they meet the exclusion criteria, as previously
mentioned.
Sample size calculation
Sample size was projected with change in VO2max as
the main outcome variable. The means and standard
deviations of a previous study [5] were examined and
Fig. 1 Schematic illustration of the research design
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the effect size for this research study was calculated.
Assuming a power of 0.80 was needed and the calcu-
lated effect size for change in VO2max was 0.30, it was
determined that approximately 16 participants would be
needed for each group [12]. It is assumed there would
be an approximate 20% dropout rate, so the aim will be
to achieve 20 participants per group.
Intervention
Testing
Testing sessions for both the experimental and control
groups will be conducted at baseline and every fourth
week during the 12-week intervention period. Testing
sessions every fourth week will help to establish the
current physiological levels to develop the exercise pre-
scription for the experimental groups.
Testing will be conducted in a university-based perform-
ance laboratory under the supervision of three exercise
physiologists. Prior to completing the testing sessions,
participants will be asked to refrain from food and drink
(other than water) for 12 hours prior to the testing session,
be well hydrated prior, avoid the use of alcohol, caffeine,
and tobacco within 24 hours of testing, be well rested, avoid
significant exertion or exercise the day of testing, and re-
port any medication use prior to testing. Testing will occur
as close to the same time of day as possible with the above
directions prior to each testing session. Following the blood
lipid profile testing (explained in detail later) and prior to
the maximal exercise test, participants will be provided a
small snack. The testing will be conducted as follows:
Dietary analysis: participants will be instructed to
not change their usual diets throughout the study
and asked to complete a 3-day dietary intake recall
including two weekdays and one weekend day to
evaluate energy intake and the proportion of
kilocalories from carbohydrates, protein, and fat.
Anthropometric measurements: participants will be
weighed on a calibrated, medical-grade scale to the
nearest 0.01 kg and height will be measured using a
stadiometer to the nearest 0.5 cm. Waist circumference
will be measured by the narrowest horizontal
circumference above the umbilicus and below the
xiphoid process to the nearest 0.5 cm [4].
Table 1 SPIRIT study calendar for the experimental group for the first 12-week intervention
Exercise intervention







Height x x x x
Weight x x x x
Resting heart rate x x x x
Resting blood pressure x x x x
Waist circumference x x x x
Low-density lipoprotein x x x x
High-density lipoprotein x x x x
Triglycerides x x x x
Blood glucose x x x x
Maximal exercise test x x x x
Verification test x x x x
3-day nutrition recall x x
Analysis
Biological variability x
Time course changes x
Incidence of response x
SPIRIT Standard Protocol Items: Recommendations for Interventional Trials
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Table 2 SPIRIT study calendar for the control group for the first 12-week intervention






Height x x x x
Weight x x x x
Resting heart rate x x x x
Resting blood pressure x x x x
Waist circumference x x x x
Low-density lipoprotein x x x x
High-density lipoprotein x x x x
Triglycerides x x x x
Blood glucose x x x x
Maximal exercise test x x x x
Verification test x x x x
3-day dietary recall x x
IPAQ x x x x
Analysis
12-week changes x
SPIRIT Standard Protocol Items: Recommendations for Interventional Trials, IPAQ International Physical Activity Questionnaire
Table 3 SPIRIT study calendar (second 12 weeks) for VO2max non-responders after the first 12-week intervention
Exercise intervention
Point of time: Pre-intervention Baseline Time 0 Week 4 Week 8 Week 12 12-week analysis
Pre-intervention
Switch of experimental group x
Testing
Height x x x x
Weight x x x x
Resting heart rate x x x x
Resting blood pressure x x x x





Maximal exercise test x x x x
Verification test x x x x
3-day nutrition recall x x
Analysis
Incidence of response x
SPIRIT Standard Protocol Items: Recommendations for Interventional Trials, VO2max maximal oxygen uptake
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Resting heart rate (RHR) and BP measurements:
procedures for RHR and BP will follow standard
guidelines [4]. In summary, participants will be required
to sit for 5 minutes with sufficient back support, feet
on the ground, and arms supported at heart level.
Resting heart rate will be recorded by using a medical-
grade pulse oximeter after the 5 minutes of seated rest.
Blood pressure will be measured using a stethoscope
and sphygmomanometer to determine left arm brachial
artery BP on consecutive measure separated by 1
minute. The mean of the systolic and diastolic measures
will be considered the resting BP.
Fasting blood glucose and lipid measurements: all
fasting lipid and blood glucose measurements will be
analyzed using the Cholestech LDX system (Alere,
Waltham, MA, USA), which has been shown to have
excellent reproducibility [13, 14]. An optics check of
the Cholestech LDX system will be completed at the
beginning of each testing session. Participants will be
asked to thoroughly wash hands with soap and rinse
with warm water. The skin will then be wiped with an
alcohol swab and allowed to dry. Using a lancet, the
distal end of the third digit of the right hand will be
punctured and a finger stick sample will be collected
using a 40 μl capillary tube with blood flowing freely
into the tube without milking the finger. The blood
sample will then be extracted into a commercially
available test cassette for analysis. Measurements of
TC, HDL, LDL, triglycerides, and blood glucose will be
obtained. Upon completion of the blood profile testing
and data collection, blood samples will be disposed of
based on standard biohazard procedures.
VO2max and verification bout: participants will
complete a modified Balke, pseudo-ramp graded
exercise test (GXT) on a power treadmill. Participants
will walk or jog at a self-selected pace with an increase
in incline of 1% every minute until volitional fatigue.
Heart rate and expired gas will be measured continuously
using a heart rate monitor and a calibrated metabolic
analyzer, respectively. Data will be analyzed following
guidelines previously reported [5]. In summary, gas
exchange data will be time averaged for every 15 seconds,
VO2max will be determined by averaging the last two
15 second samples, and maximal HR will be the highest
achieved HR during the GXT.
Since a verification procedure has been found to be
effective in middle-aged and older adults to confirm
VO2max [15], this procedure will be used to ensure par-
ticipants have reached maximal capacity. The verifica-
tion trial will be performed 20 minutes after the GXT as
recommended elsewhere [16] and has been confirmed to
be an effective procedure at altitude [17]. The verifica-
tion bout will consist of a workload that is 105% of the
maximal workload during the GXT (last fully com-
pleted stage) as this workload has been shown to be
sufficient to elicit verification test durations of 2–3
minutes [15, 18] and will continue until volitional
fatigue. Analysis of the verification bout will follow
the same protocol as the GXT. ‘True’ VO2max will
be considered to be attained if the GXT and verifica-
tion bout are within ± 3% [15]. If participants are un-
able to reach VO2max, they will be asked to repeat
the trial no sooner than 24 h later.
The control group will be asked to maintain their nor-
mal lifestyle activity habits. Therefore, in addition to the
previously stated battery of testing, control participants
will also complete the International Physical Activity
Questionnaire (IPAQ) every fourth week at the testing
session.
Biological variability and technical error
In order to establish criteria to categorize participants as
responders or non-responders, the biological variability
will be established to determine the TE. Therefore, from
the pool of experimental research participants, 15 partic-
ipants will be randomly selected based on when the re-
ferral or inquiry into the wellness program is received
(i.e., participants 1, 3, 5, 7, etc. until 15 confirmed partic-
ipants have been reached. If there are not 15 participants
after the first round, then participants 2, 4, 6, etc. will be
asked until the desired total of 15 participants is met).
Participants will be asked to complete the baseline test-
ing assessments twice within a 2-week period to deter-
mine the day-to-day biological variability. The biological
variability will be combined with the typical error of the
equipment utilized (sourced from the literature and
company of the equipment) to determine the TE. More
details related to the statistical approaches are located in
the statistical analysis section.
Exercise intervention
After the completion of the baseline testing, participants
will be randomly allocated to either the individualized or
standardized arms at a 1:1 ratio using a computerized
stratified minimization sequence. One of the primary in-
vestigators will have knowledge of the treatment groups
to which participants have been allocated in order to
interpret test results and prescribe target exercise inten-
sities. However, this same investigator will not be in-
volved in the implementation of the exercise training
programs (to be completed by research assistants) in
order to mitigate researcher bias. Participants will then
be asked to come to the laboratory on Monday,
Wednesday, and Friday to take part in the community
wellness program and subsequent research. Upon arrival
each day, participants will be asked to rest comfortably
for 5 minutes in the seated position. Then, their resting
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BP and HR will be recorded. Following the resting
measurements, participants will complete a 5-minute
warm-up starting at a low and progressively increasing
intensity until they are ready to begin their CRF exercise
session. At this point, participants will be asked to stay
within the designated HR (described in further detail
below) outlined on their exercise log as determined
based on their experimental group and week of experi-
mental trial. At approximately 1/3 and 2/3 the total ses-
sion time, an exercise physiologist or research assistant
will record their current HR, rating of perceived exertion
(scale 1–10), intensity of aerobic equipment, and any
other pertinent notes. At the end of the CRF exercise
session, the participant will be asked to complete a cool-
down in which the exercise intensity is gradually
reduced. While resistance training is not part of this
proposed experiment, it is an integral part of the com-
munity wellness program and could be a confounding
factor to the overall incidence of response. Therefore, all
participants will be asked to complete the resistance
training after the CRF training session is completed in
order to have consistency among all participants. During
the first 4 weeks, there will be no resistance training.
During the next 4 weeks (week 4–8), there will be a
learning and anatomical adaptation phase to resistance
training in which proper technique and range of motion
will be emphasized and participants will be acclimated
to the resistance training machines. During the last
4 weeks (week 8–12) participants will complete one set
of 8–12 repetitions on eight machine-based resistance
training exercises and progress to two sets by the end of
the 12th week [19].
Determination of workload
For the standardized group, the workload will be deter-
mined based on %HRR and completed based on the
following calculation:
HRR ¼ Maximal HR‐Resting HRð Þ  Desired Percentage½  þ Resting HR
For the individualized group, the workload will be
determined based on ventilatory threshold values as pre-
viously described [5, 20] to determine VT1 and VT2.
The criteria used for determining VT1 and VT2 will be
a visual analysis of figures of time plotted against the
relative respiratory variable – ventilatory equivalents of
oxygen (VE/VO2) and ventilatory equivalents of carbon
dioxide (VE/VCO2). Determination of VT1 will be an in-
crease in VE/VO2 with no increase in VE/VCO2 and
moving away from linearity of VE, whereas VT2 will be
a simultaneous increase in both VE/VO2 and VE/VCO2.
Calculations of HR values associated with ventilatory
threshold (VT) values will be calculated prior to exercise
sessions and with following HR ranges:
 Target HR > VT1 = HR range of 10 bpm below VT1
to the HR at VT1
 Target HR ≥VT1 to < VT2 =HR range of 15 bpm
above VT1 and below VT2
 Target HR ≥VT2 =HR range of 10 bpm above VT2
Exercise volume will be prescribed based on energy
expenditure per kg of body weight a week (kcal · kg−1 ·
week−1) to implement an isocaloric exercise volume (i.e.,
in terms of kilocalories [kcal] per kg a week) across indi-
viduals and groups. Previous research has found that en-
ergy expenditure ranging from 4 kcal · kg−1 · week−1 [21]
to 23 kcal · kg−1 · week−1 [22–25] have positive effects on
CRF and cardiometabolic responses to exercise. There-
fore, this study will utilize a similar 12-week exercise
protocol as previously described [5], while implementing
a standardized isocaloric volume (kcal · kg−1 · week−1)
instead of a designated time for each exercise session.
Exercise progression will follow standard guidelines that
have been previously established [4]. Figure 2 illustrates
the exercise progression following baseline testing
through the 12-week intervention for both experimental
groups while Tables 1 and 2 show the SPIRIT study
schedule for experimental and control participants,
respectively.
Time course changes over 12 weeks
Currently, there is no literature investigating the time
course changes of VO2max and cardiometabolic risk fac-
tor values between a standardized and individualized
CRF exercise program. Therefore, since testing will
occur every fourth week, the time course changes over
the first 12 weeks of the CRF training intervention will
be highlighted and addressed. These data will help fur-
ther analyze the incidence of response during 12 weeks
of structured CRF training and gain insight into the time
course changes associated with CRF training for each
individual and based on the CRF training intensity (stan-
dardized or individualized).
Categorizing responders and non-responders
Following the 12-week intervention, the participants will
be categorized as responders and non-responders (see
statistical analysis section for further details) for each
testing measurement. While each testing measurement
will be evaluated, the overreaching categorization of re-
sponder and non-responder will be based on VO2max
due to the profound health and performance implica-
tions of this measurement.
Modifying the prescription of non-responders
For the participants that are categorized as responders
after the initial 12 weeks, they will be completed with the
study. However, participants that were non-responders
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based on VO2max changes will be asked to complete a
subsequent 12-week intervention. During this second 12-
week intervention, participants will switch their exercise
intensity prescription (i.e., if a participant in the standard-
ized group was categorized as a non-responder, they will
complete the second 12 weeks in the individualized
group). The experimental design including the exercise
prescription and testing (baseline and post-testing) will
follow the same schedule and protocol. However, during
week 4 and 8 the testing sessions will not include blood
analysis. The SPIRIT study schedule for the second 12-
week intervention can be seen in Table 3.
At the completion of the second 12-week intervention,
the participants will again be categorized as responders
or non-responders based on the new baseline and 12-
week testing values. This crossover design intervention
will help to gain insight on whether or not ‘non-re-
sponders’ can become responders if the intensity of the
exercise prescription is modified.
Data and confidentiality management
Electronic data will be coded, entered, and stored into a
secure (password-protected) database on Western State
Colorado University’s campus. All paper data, including
consent forms, medical history documents, and daily ex-
ercise logs, will be stored in a secured locked cabinet in
the Western State Colorado University Human Subject’s
office. Only the primary investigators will have access to
the data.
Due to the nature of the study, participants will be
exercising in an environment with other members from
the study. Therefore, anonymity of identity cannot be
guarantee throughout the study. However, no research
participant will be able to see or access any personal
information – medical documents, exercise log, medica-
tions, etc. To ensure participant safety when exercising,
researcher assistants delivering the exercise will be in-
formed of relevant information that may influence how
the participant responds to exercise. Any data collected
Fig. 2 A detailed flow schematic of the exercise prescription for the experimental groups. HRR heart rate reserve, kcal kilocalories, kg kilograms,
VT1 first ventilatory threshold, VT2 second ventilatory threshold
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and displayed in results of scientific manuscripts will be
displayed in a way which does not disclose individual
identity.
Statistical analysis
All analyses will be performed using IBM SPSS Version
22.0 (Armonk, NY, USA) and GraphPad Prism 6.0
(GraphPad Software, San Diego, CA, USA).
Biological variability
Intraclass correlation (ICC) of variation, typical error
and co-efficient of variation (CV) for VO2max, resting
HR, resting BP, and fasting blood glucose, total choles-
terol, HDL, and LDL will be calculated as described
previously [26]. The CV will be combined with the
measurement error of the testing to determine the TE.
The TE will be used to categorize responders and non-
responders. In summary, for all criteria tested the changes
in pre- to post- intervention will be analyzed with
responders having a change > TE and non-responders
having a change that is ≤TE.
Time course changes
Measures of centrality and spread will be presented as
mean ± standard deviation (SD) and ranges will be re-
ported for each measure. The precision of estimates will
be reported as 90% confidence limits. Baseline-dependent
variables will be compared using general linear model
(GLM) ANOVA and Tukey post hoc tests, when applic-
able. Because baseline and every fourth week program
data will be available after the completion of the first
12 weeks the effect of training on CRF (VO2max) and
cardiometabolic measurements (TC, HDL, LDL, resting
BP, and resting HR) will be determined using repeated-
measures GLM-ANOVA with the exercise intensity (indi-
vidualized or standardized) as the between subjects factor.
Between group 12-week changes will be analyzed using
GLM-ANOVA and Tukey post hoc tests, when appropri-
ate. The assumption of normality will be tested by exam-
ining normal plots of the residuals in ANOVA models and
will be regarded as normally distributed if Shapiro-Wilk
tests are not significant [12]. Effect sizes will be calculated
using means and pooled standard deviations. Method of
data analysis will be analysis by treatment administered.
Only participants who complete ≥ 70% exercise training
sessions and strictly adhere to target exercise intensity will
be included in the statistical analysis. The probability of
making a type I error will be set at p ≤ 0.05 for all statis-
tical analyses.
Incidence of response
Delta values (Δ) will be calculated (post-testing minus
baseline value divided by baseline value) for percent
change in relative VO2max, TC, HDL, LDL, resting BP
and resting HR and participants will be categorized as:
‘1’ = responder (% Δ > TE) or ‘0’ = non-responder (% Δ ≤
TE). Chi-squared (χ2) tests will be subsequently used to
analyze the point prevalence of responders and non-
responders to exercise training separated by exercise in-
tensity group (individualized and standardized) between
baseline and the end of the end the first 12-week inter-
vention. Only participants who complete ≥ 70% exercise
training sessions and strictly adhere to target exercise
intensity will be included in the statistical analysis. The
probability of making a type I error will be set at p ≤
0.05 for all statistical analyses.
In order to make inferences about the true values
(population values) of the effect of both exercise inter-
ventions on VO2max and cardiometabolic factors, the
uncertainty in effect will be expressed as 90% confidence
limits and the likelihood the true value of the effect rep-
resents a substantial and clinically meaningful change
(harm or benefit). Effects will be declared unclear if the
confidence interval overlapped thresholds for substan-
tiveness or the effect could be substantially positive and
negative or beneficial and detrimental. All probabilistic
magnitude-based inferences will be calculated using a
published spreadsheet [27].
Discussion
There has been a considerable amount of individual
variability reported in the literature related to the re-
sponse of CRF measurements (specifically, VO2max and
peak aerobic ability [VO2peak]). However, there is still
an overall lack of understanding as to why this variability
occurs. Unfortunately, there is minimal consistency in
methodology and the criteria for determining incidence
of response leading to the overall findings indicating
there are changes in training responsiveness of −33 to
+76% [7]. However, some of the data associated with in-
dividual responses may be misleading as measurements
were recorded as peak values [8, 28, 29] and may not be
a direct representation of the maximal efforts for partici-
pants and, therefore, not an accurate representation of
true physiological adaptations.
In order to have an all-inclusive definition for inci-
dence of response the TE must be taken into account
[10]. Therefore, it would be important to know
biological variability and measurement error for each
outcome to determine whether responses are beyond
that of the TE. Two recent investigations [5, 30] utilized
TE to determine response rate by defining a responder
as an individual with improvements from pre- to post-
training by > TE in a positive direction and, in contrast, an
individual who improves by ≤TE as a non-responder.
Nevertheless, for the two aforementioned studies, values
for day-to-day biological variability were used from previ-
ously published work and may not be directly applicable
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to the population being studied or the environmental con-
ditions in which data collection takes place.
Conventionally, results of exercise-based studies are
reported as the mean and standard deviation [31] and
only illustrate the main effects and group differences of
training responsiveness [32]. Overall, there is a lack in
attention to individual differences with these conven-
tional methods of reporting data since nearly 32% of
measurements (distributed normally) fall outside of one
standard deviation. Recent literature proposes reporting
not only the mean, standard deviation, and group differ-
ences, but also individual responses to the training pro-
gram [31, 32] or at least ranges of endurance changes
[30]. This approach will strengthen study findings and
provide further insight into the phenomenon of individ-
ual variability and training responsiveness.
From the HERITAGE Family Study [33], a large, well-
controlled, 20-week standardized endurance training
program, insight was gained on the incidence of re-
sponse. It was reported that genetics may play a critical
role in the incidence of response [34] with trainability of
VO2max linked to familial aggregation [35]. However, a
potentially overlooked factor in the individual variability
may be linked to poor methodology of exercise prescrip-
tion. Indeed, due to the theoretical and physiological
mechanisms of exercise prescription, utilization of a
threshold-based measurement for exercise prescription
has been suggested to decrease the incidence of non-
response and improve CRF and cardiometabolic factors
compared to the traditional approach using intensities
set relative to VO2max, HRmax, VO2R, or HRR [36].
However, there have been few studies that have reported
individual responses following training relative to a
threshold measurement [31]. To the best of our know-
ledge, there is currently only one study reporting indi-
vidual responses to training comparing set intensities
based on the first ventilatory threshold (VT1) and the
second ventilatory threshold (VT2) measurements and
percentage of HRR [5]. During incremental exercise,
VT1 is the point at which increases in ventilation
become non-linear (an increase in the ventilatory equiv-
alents of oxygen [VE/VO2] with no increase in the venti-
latory equivalents of carbon dioxide [VE/VCO2]) and
VT2 is the point at which there is an accumulation of
blood lactate due to the inability to buffer the amount of
lactate produced (simultaneous increase in both VE/VO2
and VE/VCO2) [37].
Traditionally, exercise intensity has been prescribed
based on a relative percent concept – based on a percent-
age of HRmax, VO2max, VO2R, or HRR. However, caution
has been advised for utilization of the relative percent
method, specifically HRmax and VO2max, as criteria to
determine workload as they may not be sufficient to elicit
the desired metabolic response [3, 38]. Furthermore,
percentages for both HRmax and VO2max correspond to
a wide range of exercise intensities relative to threshold
measurements [39]. For example, with exercise intensities
between 58% and 75% of VO2max, some participants were
found to be above while others were reported to be below
their individual anaerobic threshold [40]. Similar findings
were noted when investigating a 12-month jogging/walk-
ing program [38]. In order to make the prescription of
exercise intensity more individualized, many researchers
have used percentages of HRR as this takes into consider-
ation not only HRmax, but also resting HR. However,
aerobic thresholds were found to be at 70% ± 10% of HRR
[41] indicating large variability in the metabolic stress
across individuals at a set percentage of HRR.
Indeed, genetics have gained a lot of attention to under-
stand the specific roles of genes and response rates. How-
ever, based on the genetic evidence to date, there are many
pathways that are associated with VO2max trainability and
nearly an unlimited combination of signaling events that
may influence the VO2max responsiveness [42, 43]. With
genetics proposed to account for less than 50% of the vari-
ance in responsiveness, the other 50% is still not well
understood.
One of the major areas in which the literature is lacking
in the understanding of training responsiveness is the in-
vestigation of an individualized approach to exercise pre-
scription and the time course changes. With the emerging
concept of ‘exercise is medicine’ and the capacity to pre-
scribe exercise to combat adverse effects of disease, the
time course changes for VO2max and cardiometabolic risk
factor measures need to be better understood to properly
identify efficacious exercise doses (i.e., intensity, volume)
that will elicit an adequate response. However, much of
the literature on time course changes utilizes standardized
methods of exercise prescription rather than individualized
approaches. To the best of our knowledge, there is no lit-
erature in time course changes of VO2max and cardiomet-
abolic risk factor outcomes with the use of a threshold-
based protocol and exercise volume individualized based
on kilocalories of expenditure per week with relation to
body mass. Similarly, results of time course changes have
traditionally been reported as only group means and
standard deviations with individual time course changes
not being reported. Based on a review of the literature,
there have only been two studies to identify individual
time course changes [44, 45]. Reporting of individual time
course changes for VO2max and cardiometabolic risk
factor measurements will help to further understand the
individual variability in training responsiveness.
Limitations
There are several limitations that merit discussion. It is
possible there may be heterogeneity in training responses
due to age alone given the large age range (30 to 75 years)
Weatherwax et al. Trials  (2016) 17:601 Page 10 of 12
that will be recruited for the current trial. However, the
age range for the target sample will be comparable to pre-
vious studies [22, 23, 33] and also reflect the likely age
range found in community exercise programs [46].
Another possible limitation is external validity given data
collection will take place at moderate altitude. Neverthe-
less, to the best of our knowledge, there is no evidence to
suggest differences in training responsiveness (i.e. re-
sponders and non-responders) between altitude-residing
individuals and sea level counterparts. A third potential
limitation is the inability to anticipate how many partici-
pants will be categorized as non-responders following the
first 12-week intervention. Indeed, this limitation could
arguably be the most significant due to the second part of
the trial (crossing over non-responders to the other pre-
scription group) being underpowered if there are a low
number of non-responders. Nevertheless, to our know-
ledge, there are no previous investigations evaluating a
crossover design to determine if non-responders can be-
come responders with a different exercise prescription
protocol. Therefore, even if the second part of the trial is
underpowered, the results would provide valuable prelim-
inary insight into the efficacy of individualized exercise
prescription.
In summary, this original randomized controlled trial
aims to (1) investigate the efficacy of an individualized ex-
ercise prescription at improving training responsiveness
and, (2) to better understand the time course changes of
training adaptations to both individualized and standard-
ized exercise intensity prescription methods. It is antici-
pated that findings from this novel trial will add to our
knowledge of how personalized exercise can enhance
training efficacy and limit training unresponsiveness.
Study status
Recruitment will commence in September of 2016. The
estimated completion date is mid-late 2018.
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